Medexpress.pl > Drugs and medical technology (en)

New truncated composition of the Economic Commission

medexpress.pl

Published March 20, 2024 09:11

New truncated composition of the Economic Commission - Header image

The Health Ministry has published the new composition of the Economic Commission.

Zrzut ekranu 2024-03-20 o... <div class='lock-content' style='border: 1px solid gray; padding: 2rem; text-align:center;background-color: rgba(0, 0, 0, 0.1);'><h3 style='font-weight: 500;font-size: 1.25rem;margin-bottom:2rem;'>Content locked</h3><p>To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at english@medexpress.pl.</p><div style='margin-top: 35px;'>If you already have an account, please <a href='/login/' style='text-decoration: underline; font-weight: 600;'>log in</a></div></div>

</div>
</div>
<div class=

Download this article in .pdf format

Topics

refundacja / Komisja Ekonomiczna

AOTMiT: The Transparency Council will evaluate drugs for lung cancer, cervical cancer and plasmocytic myeloma, among others. Nov. 22, 2024

Nov. 22, 2024

PZ demands removal of obligation on doctors to set reimbursement levels for drugs Nov. 15, 2024

Nov. 15, 2024

Reimbursement right finally assigned to patient Nov. 6, 2024

Nov. 6, 2024

AOTMiT: The Transparency Council will evaluate the diabetes drug Oct. 31, 2024

Oct. 31, 2024

The reimbursement procedure will be cheaper and shorter. The Ministry has published a list of substances for which this will be possible Oct. 18, 2024

Oct. 18, 2024

AOTMiT: The Transparency Council will evaluate drugs for lung cancer, cervical cancer and plasmocytic myeloma, among others. Nov. 22, 2024

Nov. 22, 2024

PZ demands removal of obligation on doctors to set reimbursement levels for drugs Nov. 15, 2024

Nov. 15, 2024

Reimbursement right finally assigned to patient Nov. 6, 2024

Nov. 6, 2024

AOTMiT: The Transparency Council will evaluate the diabetes drug Oct. 31, 2024

Oct. 31, 2024

The reimbursement procedure will be cheaper and shorter. The Ministry has published a list of substances for which this will be possible Oct. 18, 2024

Oct. 18, 2024

Szukaj nowych pracowników

Dodaj ogłoszenie już za 4 zł dziennie*.

Dodaj w 2 minuty

* 4 zł netto dziennie. Minimalny okres ekspozycji ogłoszenia to 30 dni.

Najciekawsze oferty pracy (przewiń)

Kierownik Apteki - Goleniów Ul. Dworcowa

Dr. Max Sp. Z O.O.

Wynagrodzenie do ustalenia

Kierownik Apteki - Sopot Ul. Kościuszki

Dr. Max Sp. Z O.O.

Wynagrodzenie do ustalenia

Kierownik Apteki - Płock Ul. Kolejowa

Dr. Max Sp. Z O.O.

Wynagrodzenie do ustalenia

Kierownik Apteki - Kościan Ul. Szczepanowskiego

Dr. Max Sp. Z O.O.

Wynagrodzenie do ustalenia

Magister Farmacji - Grodków Ul. Rynek

Dr. Max Sp. Z O.O.

Wynagrodzenie do ustalenia

Magister Farmacji - Brzeziny

Dr. Max Sp. Z O.O.

Wynagrodzenie do ustalenia

Magister Farmacji - Chorzów

Dr. Max Sp. Z O.O.

Wynagrodzenie do ustalenia

Lekarz POZ

Outworking

Wynagrodzenie do ustalenia

Magister Farmacji - Olsztyn Ul. Metalowa

Dr. Max Sp. Z O.O.

Wynagrodzenie do ustalenia

Magister Farmacji - Rabka Zdrój

Dr. Max Sp. Z O.O.

Wynagrodzenie do ustalenia

Magister Farmacji - Szczecin - Ul. Struga

Dr. Max Sp. Z O.O.

Wynagrodzenie do ustalenia

Magister Farmacji - Tarnowskie Góry (pół etatu)

Dr. Max Sp. Z O.O.

Wynagrodzenie do ustalenia

Magister Farmacji - Warszawa Ul. Patriotów

Dr. Max Sp. Z O.O.

Wynagrodzenie do ustalenia

Technik Farmaceutyczny - Inowrocław

Dr. Max Sp. Z O.O.

Wynagrodzenie do ustalenia

Technik Farmaceutyczny - Jaworzno

Dr. Max Sp. Z O.O.

Wynagrodzenie do ustalenia

Zobacz więcej ogłoszeń

Read also

Prof-Tomasz-Szczepanski---YouTube---Google-Chrome-2019-02-08-135944

Prof. Tomasz Szczepanski on hemophilia: We have reached a certain level of quality of life, but we are still a little short of talking about normal life May 13, 2024

May 13, 2024

AOTMiT: There is the first list of cardiovascular drugs without reimbursement claims June 14, 2024

June 14, 2024

Medical Fund

Three items on ministerial list of technologies with high level of innovation July 4, 2024

July 4, 2024

Drug-resistant depression: not all patients who deserve it can benefit from drug program July 9, 2024

July 9, 2024

These drugs will not be funded under RDTL July 30, 2024

July 30, 2024

Stop Friedreich's Ataxia Aug. 5, 2024

Aug. 5, 2024

Popular tablets with honey and lemon withdrawn from the market in Poland Sept. 25, 2024

Sept. 25, 2024

AOTMiT: Transparency Council on preventive mastectomy, cystic fibrosis and newborn screening, among others Oct. 28, 2024

Oct. 28, 2024

Prof. Tomasz Szczepanski on hemophilia: We have reached a certain level of quality of life, but we are still a little short of talking about normal life May 13, 2024

May 13, 2024

AOTMiT: There is the first list of cardiovascular drugs without reimbursement claims June 14, 2024

June 14, 2024

Medical Fund

Three items on ministerial list of technologies with high level of innovation July 4, 2024

July 4, 2024

Drug-resistant depression: not all patients who deserve it can benefit from drug program July 9, 2024

July 9, 2024

These drugs will not be funded under RDTL July 30, 2024

July 30, 2024

Stop Friedreich's Ataxia Aug. 5, 2024

Aug. 5, 2024

Popular tablets with honey and lemon withdrawn from the market in Poland Sept. 25, 2024

Sept. 25, 2024

AOTMiT: Transparency Council on preventive mastectomy, cystic fibrosis and newborn screening, among others Oct. 28, 2024

Oct. 28, 2024

New truncated composition of the Economic Commission

Similar articles

AOTMiT: The Transparency Council will evaluate drugs for lung cancer, cervical cancer and plasmocytic myeloma, among others. Nov. 22, 2024

PZ demands removal of obligation on doctors to set reimbursement levels for drugs Nov. 15, 2024

Reimbursement right finally assigned to patient Nov. 6, 2024

AOTMiT: The Transparency Council will evaluate the diabetes drug Oct. 31, 2024

The reimbursement procedure will be cheaper and shorter. The Ministry has published a list of substances for which this will be possible Oct. 18, 2024

AOTMiT: The Transparency Council will evaluate drugs for lung cancer, cervical cancer and plasmocytic myeloma, among others. Nov. 22, 2024

PZ demands removal of obligation on doctors to set reimbursement levels for drugs Nov. 15, 2024

Reimbursement right finally assigned to patient Nov. 6, 2024

AOTMiT: The Transparency Council will evaluate the diabetes drug Oct. 31, 2024

The reimbursement procedure will be cheaper and shorter. The Ministry has published a list of substances for which this will be possible Oct. 18, 2024

Szukaj nowych pracowników

Dodaj ogłoszenie już za 4 zł dziennie*.

Najciekawsze oferty pracy (przewiń)

Kierownik Apteki - Goleniów Ul. Dworcowa

Kierownik Apteki - Sopot Ul. Kościuszki

Kierownik Apteki - Płock Ul. Kolejowa

Kierownik Apteki - Kościan Ul. Szczepanowskiego

Magister Farmacji - Grodków Ul. Rynek

Magister Farmacji - Brzeziny

Magister Farmacji - Chorzów

Lekarz POZ

Magister Farmacji - Olsztyn Ul. Metalowa

Magister Farmacji - Rabka Zdrój

Magister Farmacji - Szczecin - Ul. Struga

Magister Farmacji - Tarnowskie Góry (pół etatu)

Magister Farmacji - Warszawa Ul. Patriotów

Technik Farmaceutyczny - Inowrocław

Technik Farmaceutyczny - Jaworzno

Read also

Prof. Tomasz Szczepanski on hemophilia: We have reached a certain level of quality of life, but we are still a little short of talking about normal life May 13, 2024

AOTMiT: There is the first list of cardiovascular drugs without reimbursement claims June 14, 2024

Three items on ministerial list of technologies with high level of innovation July 4, 2024

Drug-resistant depression: not all patients who deserve it can benefit from drug program July 9, 2024

These drugs will not be funded under RDTL July 30, 2024

Stop Friedreich's Ataxia Aug. 5, 2024

Popular tablets with honey and lemon withdrawn from the market in Poland Sept. 25, 2024

AOTMiT: Transparency Council on preventive mastectomy, cystic fibrosis and newborn screening, among others Oct. 28, 2024

Prof. Tomasz Szczepanski on hemophilia: We have reached a certain level of quality of life, but we are still a little short of talking about normal life May 13, 2024

AOTMiT: There is the first list of cardiovascular drugs without reimbursement claims June 14, 2024

Three items on ministerial list of technologies with high level of innovation July 4, 2024

Drug-resistant depression: not all patients who deserve it can benefit from drug program July 9, 2024

These drugs will not be funded under RDTL July 30, 2024

Stop Friedreich's Ataxia Aug. 5, 2024

Popular tablets with honey and lemon withdrawn from the market in Poland Sept. 25, 2024

AOTMiT: Transparency Council on preventive mastectomy, cystic fibrosis and newborn screening, among others Oct. 28, 2024

Medexpress

About us

Follow us

Zapisz się do newslettera